Gold(I) N-heterocyclic carbene complexes with an "activable" ester moiety: Possible biological applications

被引:38
作者
Bertrand, Benoit [1 ,2 ]
Bodio, Ewen [2 ]
Richard, Philippe [2 ]
Picquet, Michel [2 ]
Le Gendre, Pierre [2 ]
Casini, Angela [1 ]
机构
[1] Univ Groningen, Res Inst Pharm, Dept Pharmacokinet Toxicol & Targeting, NL-9713 AV Groningen, Netherlands
[2] Univ Bourgogne, CNRS, Inst Chim Mol, UMR 6302, Dijon, France
关键词
Gold(I) NHC compounds; Functionalized NHC ligands; Antiproliferative activity; Cancer; ANTICANCER AGENTS; IN-VITRO; ANTITUMOR AGENTS; ARENE COMPLEXES; METALLODRUGS; CHEMISTRY; RUTHENIUM; INSIGHTS; DRUGS;
D O I
10.1016/j.jorganchem.2014.03.020
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
While N-heterocyclic carbenes (NHC) are ubiquitous ligands in catalysts for organic or industrial synthesis, their potential to form transition metal complexes for medicinal applications has still to be exploited. Within this frame, new Au(I)-NHC compounds have been synthesized and structurally characterized via different methods. The solid state structure of one of these compounds was also established by X-ray crystallography. Of note, three of them bear a pentafluorophenolic ester group as a possible "activable" moiety for further functionalization, which allowed tethering an alkyl amine ligand or another Au(I)-phosphine complex featuring a pendant amine function via microwave activation. The obtained compounds have been tested for their antiproliferative effects in human ovarian cancer A2780 cells, and in non-tumorigenic human embryonic kidney HEK-293T cells, showing promising anticancer properties and a certain selectivity towards cancerous cells. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 37 条
  • [1] SIR97:: a new tool for crystal structure determination and refinement
    Altomare, A
    Burla, MC
    Camalli, M
    Cascarano, GL
    Giacovazzo, C
    Guagliardi, A
    Moliterni, AGG
    Polidori, G
    Spagna, R
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1999, 32 : 115 - 119
  • [2] Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents
    Barnard, PJ
    Baker, MV
    Berners-Price, SJ
    Day, DA
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2004, 98 (10) : 1642 - 1647
  • [3] Barnes KR, 2004, MET IONS BIOL SYST, V42, P143
  • [4] Bertrand B., 2014, DALTON T
  • [5] Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
    Bindoli, Alberto
    Rigobello, Maria Pia
    Scutari, Guido
    Gabbiani, Chiara
    Casini, Angela
    Messori, Luigi
    [J]. COORDINATION CHEMISTRY REVIEWS, 2009, 253 (11-12) : 1692 - 1707
  • [6] Oxali-titanocene Y:: A potent anticancer drug
    Claffey, James
    Hogan, Megan
    Mueller-Bunz, Helge
    Pampillon, Clara
    Tacke, Matthias
    [J]. CHEMMEDCHEM, 2008, 3 (05) : 729 - 731
  • [7] Emerging protein targets for metal-based pharmaceutical agents: An update
    de Almeida, Andreia
    Oliveira, Bruno L.
    Correia, Joao D. G.
    Soveral, Graca
    Casini, Angela
    [J]. COORDINATION CHEMISTRY REVIEWS, 2013, 257 (19-20) : 2689 - 2704
  • [8] Farrell N, 2004, MET IONS BIOL SYST, V42, P251
  • [9] Farrugia L. J., 1999, J. Appl. Crystallogr, V32, P837, DOI [10.1107/S0021889812029111, DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020]
  • [10] Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability
    Gabbiani, Chiara
    Casini, Angela
    Kelter, Gerhard
    Cocco, Fabio
    Cinellu, Maria Agostina
    Fiebig, Heinz-Herbert
    Messori, Luigi
    [J]. METALLOMICS, 2011, 3 (12) : 1318 - 1323